These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35209701)

  • 1. Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand.
    Dechaphunkul A; Thongwatchara P; Thongsuksai P; Dechaphunkul T; Geater SL
    J Pathol Transl Med; 2022 May; 56(3):126-133. PubMed ID: 35209701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
    Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
    Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.
    Theurer JA; Stecho W; Yoo J; Kwan K; Wehrli B; Harry V; Black M; Pinto N; Winquist E; Palma D; Richter S; Barrett JW; Danielle MacNeil S; Fung K; Howlett CJ; Nichols AC
    Pathol Oncol Res; 2016 Jan; 22(1):35-40. PubMed ID: 26271341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
    Wirtz ED; Hoshino D; Maldonado AT; Tyson DR; Weaver AM
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):543-9. PubMed ID: 25855885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of
    Borkowska EM; Barańska M; Kowalczyk M; Pietruszewska W
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.
    McBride SM; Rothenberg SM; Faquin WC; Chan AW; Clark JR; Ellisen LW; Wirth LJ
    Head Neck; 2014 Aug; 36(8):1181-8. PubMed ID: 23852799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
    Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
    JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
    Dirican E; Kaya Z; Gullu G; Peker I; Ozmen T; Gulluoglu BM; Kaya H; Ozer A; Akkiprik M
    Asian Pac J Cancer Prev; 2014; 15(21):9327-33. PubMed ID: 25422220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of PIK3CA gene mutations with head and neck squamous cell carcinomas.
    Kommineni N; Jamil K; Pingali UR; Addala L; M V; Naidu M
    Neoplasma; 2015; 62(1):72-80. PubMed ID: 25563369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
    BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
    Qiu W; Tong GX; Manolidis S; Close LG; Assaad AM; Su GH
    Int J Cancer; 2008 Mar; 122(5):1189-94. PubMed ID: 17990317
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kusaba Y; Kajihara I; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Sawamura S; Makino K; Aoi J; Masuguchi S; Fukushima S
    Intractable Rare Dis Res; 2023 Aug; 12(3):206-207. PubMed ID: 37662619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma.
    Zhang L; Shi L; Zhao X; Wang Y; Yue W
    Onco Targets Ther; 2013; 6():497-502. PubMed ID: 23674897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma.
    van Kempen PM; Verdam FJ; de Poel E; Braunius WW; de Weger RA; van Es RJ; Grolman W; Willems SM
    Pathobiology; 2015; 82(1):21-27. PubMed ID: 25765855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for mutations in the hotspot mutation regions of PIK3CA gene in nasopharyngeal carcinoma].
    Liu P; Li DJ; Qin HD; Zhang RH; Chen LZ; Zeng YX
    Ai Zheng; 2007 Jan; 26(1):15-20. PubMed ID: 17222361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer.
    Schmidt H; Kulasinghe A; Allcock RJN; Tan LY; Mokany E; Kenny L; Punyadeera C
    Diagnostics (Basel); 2018 Nov; 8(4):. PubMed ID: 30501041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
    Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
    Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
    Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.